These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 22330909)
1. Crystal structures of KPC-2 β-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226. Ke W; Bethel CR; Papp-Wallace KM; Pagadala SR; Nottingham M; Fernandez D; Buynak JD; Bonomo RA; van den Akker F Antimicrob Agents Chemother; 2012 May; 56(5):2713-8. PubMed ID: 22330909 [TBL] [Abstract][Full Text] [Related]
2. Penam sulfones and β-lactamase inhibition: SA2-13 and the importance of the C2 side chain length and composition. Rodkey EA; Winkler ML; Bethel CR; Pagadala SR; Buynak JD; Bonomo RA; van den Akker F PLoS One; 2014; 9(1):e85892. PubMed ID: 24454944 [TBL] [Abstract][Full Text] [Related]
3. Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030. Nguyen NQ; Krishnan NP; Rojas LJ; Prati F; Caselli E; Romagnoli C; Bonomo RA; van den Akker F Antimicrob Agents Chemother; 2016 Jan; 60(3):1760-6. PubMed ID: 26729491 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases. Ke W; Bethel CR; Thomson JM; Bonomo RA; van den Akker F Biochemistry; 2007 May; 46(19):5732-40. PubMed ID: 17441734 [TBL] [Abstract][Full Text] [Related]
5. KPC-2 β-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate. Mehta SC; Furey IM; Pemberton OA; Boragine DM; Chen Y; Palzkill T J Biol Chem; 2021; 296():100155. PubMed ID: 33273017 [TBL] [Abstract][Full Text] [Related]
6. Local interactions with the Glu166 base and the conformation of an active site loop play key roles in carbapenem hydrolysis by the KPC-2 β-lactamase. Furey IM; Mehta SC; Sankaran B; Hu L; Prasad BVV; Palzkill T J Biol Chem; 2021; 296():100799. PubMed ID: 34022225 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study. Krishnan NP; Nguyen NQ; Papp-Wallace KM; Bonomo RA; van den Akker F PLoS One; 2015; 10(9):e0136813. PubMed ID: 26340563 [TBL] [Abstract][Full Text] [Related]
8. Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276. Papp-Wallace KM; Taracila MA; Smith KM; Xu Y; Bonomo RA Antimicrob Agents Chemother; 2012 Aug; 56(8):4428-38. PubMed ID: 22687511 [TBL] [Abstract][Full Text] [Related]
10. Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase. Papp-Wallace KM; Bethel CR; Distler AM; Kasuboski C; Taracila M; Bonomo RA Antimicrob Agents Chemother; 2010 Feb; 54(2):890-7. PubMed ID: 20008772 [TBL] [Abstract][Full Text] [Related]
11. Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses. Alsenani TA; Rodríguez MM; Ghiglione B; Taracila MA; Mojica MF; Rojas LJ; Hujer AM; Gutkind G; Bethel CR; Rather PN; Introvigne ML; Prati F; Caselli E; Power P; van den Akker F; Bonomo RA Antimicrob Agents Chemother; 2023 Jan; 67(1):e0093022. PubMed ID: 36602311 [TBL] [Abstract][Full Text] [Related]
12. Structures of SHV-1 β-lactamase with penem and penam sulfone inhibitors that form cyclic intermediates stabilized by carbonyl conjugation. Ke W; Pattanaik P; Bethel CR; Sheri A; Buynak JD; Bonomo RA; van den Akker F PLoS One; 2012; 7(11):e49035. PubMed ID: 23145056 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure of a preacylation complex of the β-lactamase inhibitor sulbactam bound to a sulfenamide bond-containing thiol-β-lactamase. Rodkey EA; Drawz SM; Sampson JM; Bethel CR; Bonomo RA; van den Akker F J Am Chem Soc; 2012 Oct; 134(40):16798-804. PubMed ID: 22974281 [TBL] [Abstract][Full Text] [Related]
14. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates. Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290 [TBL] [Abstract][Full Text] [Related]
15. Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Nukaga M; Yoon MJ; Taracilia MA; Hoshino T; Becka SA; Zeiser ET; Johnson JR; Papp-Wallace KM ACS Infect Dis; 2021 Apr; 7(4):826-837. PubMed ID: 33723985 [No Abstract] [Full Text] [Related]
16. Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone. Padayatti PS; Sheri A; Totir MA; Helfand MS; Carey MP; Anderson VE; Carey PR; Bethel CR; Bonomo RA; Buynak JD; van den Akker F J Am Chem Soc; 2006 Oct; 128(40):13235-42. PubMed ID: 17017804 [TBL] [Abstract][Full Text] [Related]